PwC Escapes Valeant Investors' $80B Price-Gouging Suit
A New Jersey federal judge Wednesday dismissed PricewaterhouseCoopers LLP from a price-gouging suit from Valeant Pharmaceuticals shareholders, finding that the investors failed to allege a motive to commit fraud. ...To view the full article, register now.
Already a subscriber? Click here to view full article